ArticleJAMA ophthalmology2020

Cost-effectiveness of Intravitreal Ranibizumab With Verteporfin Photodynamic Therapy Compared With Ranibizumab Monotherapy for Patients With Polypoidal Choroidal Vasculopathy.

Brett Doble et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.